glp-1 cause muscle loss Sarcopenia in the era of receptor agonists: Implications for the internist A lot of people assume

It is important to note that these head-to-head studies varied in many ways, including in the dosages studied and in the prior and background therapies permitted

Nutrees focus is thoughtful dosing, close follow-up, and care that feels sustainable in real life

Studies involving amphetamines also suggest that GLP-1 receptor activation may reduce stimulant-related reward behaviors and hyperactivity, although no clinical trials for stimulant use disorder were identified in the review

An analysis by Prime Therapeutics found that only 27% of people taking GLP-1 drugs were still taking the medication a year later due to side effects or the cost of prescriptions